ulcerative colitis

J&J and Protagonist’s icotrokinra scores in Phase IIb UC study
Clinical Trials Arena
Tue, 03/11/25 - 11:13 am
JNJ
Protagonist Therapeutics
ulcerative colitis
clinical trials
icotrokinra
Where Will Eli Lilly Be in 5 Years?
Motley Fool
Sun, 03/2/25 - 09:41 pm
Eli Lilly
diabetes
obesity
cancer
ulcerative colitis
OSE’s UC therapy prompts 16% clinical remission after ten weeks
Clinical Trials Arena
Mon, 02/24/25 - 10:21 am
OSE Therapeutics
lusvertikimab
clinical trials
ulcerative colitis
J&J’s fully subcutaneous Tremfya shows 27.6% clinical remission in UC
Clinical Trials Arena
Sun, 02/23/25 - 10:46 pm
JNJ
Tremfya
ulcerative colitis
clinical trials
Teva Pharma and Alvotech launch US biosimilar to J&J's Stelara
MSN/Reuters
Fri, 02/21/25 - 11:18 am
Teva Pharmaceutical
Alvotech
biosimilars
Stelara
autoimmune disease
Selarsdi
Crohn's Disease
ulcerative colitis
plaque psoriasis
Sionna, Odyssey join queue of biotechs testing investors’ IPO interest
BioPharma Dive
Tue, 01/21/25 - 11:16 am
IPOs
Sionna Therapeutics
cystic fibrosis
Odyssey Therapeutics
ulcerative colitis
Palisade Bio begins MAD cohorts of Phase Ia/b ulcerative colitis therapy trial
Clinical Trials Arena
Fri, 01/17/25 - 11:25 am
Palisade Bio
clinical trials
PALI-2108
ulcerative colitis
Cristcot‘s Phase III ulcerative colitis suppository trial meets endpoints
Clinical Trials Arena
Thu, 01/9/25 - 11:13 am
Cristcot
clinical trials
ulcerative colitis
Sorriso Pharma’s UC treatment hits Phase Ib endpoints
Clinical Trials Arena
Fri, 12/20/24 - 11:18 am
Sorriso Pharma
ulcerative colitis
clinical trials
SOR102
Innovent’s trial of picankibart for ulcerative colitis meets primary endpoint
Clinical Trials Arena
Thu, 10/17/24 - 09:36 am
Innovent Biologics
ulcerative colitis
picankibart
clinical trials
FDA expands J&J's psoriasis drug for inflammatory bowel disease
Reuters
Wed, 09/11/24 - 10:59 pm
JNJ
Tremfya
FDA
ulcerative colitis
AbbVie’s Skyrizi Wins EU Nod for Ulcerative Colitis, Helps to Weather Humira Patent Cliff
BioSpace
Mon, 07/29/24 - 10:31 am
AbbVie
Europe
Skyrizi
ulcerative colitis
FDA approves Abbvie's Skyrizi for ulcerative colitis
PR Newswire
Tue, 06/18/24 - 07:56 pm
AbbVie
FDA
Skyrizi
ulcerative colitis
Where competition is heating up in pharma
Pharma Voice
Fri, 05/24/24 - 11:06 am
competition
oncology
immunology
COPD
RSV
ulcerative colitis
GSK
JNJ
Moderna Therapeutics
AltruBio lands up to $225M after shift to immune drug research
BioPharma Dive
Tue, 05/21/24 - 11:18 am
AltruBio
funding
ulcerative colitis
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena
Tue, 05/21/24 - 11:17 am
JNJ
Tremfya
ulcerative colitis
clinical trials
Pfizer’s Velsipity UK approval to raise competition in ulcerative colitis market
Biopharma Reporter
Mon, 04/15/24 - 11:11 am
Pfizer
Velsipity
UK
ulcerative colitis
Johnson & Johnson files sBLA for ulcerative colitis treatment
Pharmaceutical Business Review
Tue, 03/12/24 - 11:19 am
JNJ
FDA
Tremfya
ulcerative colitis
Biora’s BT-600 novel drug-device may revolutionise targeted colon therapy
Biopharma Reporter
Thu, 02/22/24 - 11:39 am
Biora Therapeutics
clinical trials
BTZ-600
drug-device combos
ulcerative colitis
Alfasigma to acquire Galapagos’ Jyseleca business
Pharmaceutical Business Review
Tue, 01/2/24 - 09:58 am
Galapagos
Alfasigma
Jyseleca
filgotinib
ulcerative colitis
rheumatoid arthritis

Pages